N-Acetyltransferase polymorphism and human cancer risk
- PMID: 21432481
- PMCID: PMC2723592
- DOI: 10.1007/BF02931254
N-Acetyltransferase polymorphism and human cancer risk
Abstract
Because of the important role ofN-acetyltransferase (NAT) enzymes in both metabolic activation and detoxification of certain precarcinogens, such as homo-and heterocyclic arylamines, extensive research in the past has focused on the relationship between the distribution of different variants of these enzymes and cancer susceptibility. In this context, we examined the relationship between the acetylator type of two NAT isozymes (NAT1 and NAT2) and cancer risk. It was shown that any independent overall association of those diseases with acetylation for eitherNATl orNAT2 is likely to be weak at most. Besides individual genetic profile, differences in the degree of exposure to environmental precarcinogens should also be considered. It was suggested that smoking and red meat intake were associated with bothNATl andNAT2 genotype in the carcinogenesis. A gene-gene interaction, even linkage betweenNATl andNAT2 may also exist.
Keywords: N-acetyltransferase; cancer risk; red meat intake; smoking.
References
-
- Badawi AF, Stern SJ, Lang NP, Kadlubar FF. Cytochrome P-450 and acetyltransferase expression as biomarkers of carcinogen-DNA adduct levels and human cancer susceptibility. Prog Clin Biol Res 1996; 395:109–40. - PubMed
-
- Grant DM, Hughes NC, Janezic SA, et al. Human acetyltransferase polymorphisms. Mutat Res 1997; 376:61–70. - PubMed
-
- Blum M, Grant DM, McBride W, Heim M, Meyer UA. Human arylamineN-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 1990;9:193–203. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous